EEA1 Human Pre-designed siRNA Set A contains three designed siRNAs for EEA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EED Human Pre-designed siRNA Set A contains three designed siRNAs for EED gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEDQ is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

EEF1A1 Human Pre-designed siRNA Set A contains three designed siRNAs for EEF1A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF1A2 Human Pre-designed siRNA Set A contains three designed siRNAs for EEF1A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF1B2 Human Pre-designed siRNA Set A contains three designed siRNAs for EEF1B2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF1D Human Pre-designed siRNA Set A contains three designed siRNAs for EEF1D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF1E1 Human Pre-designed siRNA Set A contains three designed siRNAs for EEF1E1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF1G Human Pre-designed siRNA Set A contains three designed siRNAs for EEF1G gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF2 Human Pre-designed siRNA Set A contains three designed siRNAs for EEF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEF2K Human Pre-designed siRNA Set A contains three designed siRNAs for EEF2K gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEFSEC Human Pre-designed siRNA Set A contains three designed siRNAs for EEFSEC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EEPD1 Human Pre-designed siRNA Set A contains three designed siRNAs for EEPD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Efavirenz (Standard) is the analytical standard of Efavirenz. This product is intended for research and analytical applications. Efavirenz (DMP 266) is a potent inhibitor of the wild-type HIV-1 reverse transcriptase with a Ki of 2.93 nM and exhibits an IC95 of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture[1].

EFCAB2 Human Pre-designed siRNA Set A contains three designed siRNAs for EFCAB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFdA-TP tetralithium is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP tetralithium inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP tetralithium inhibits HIV-1 RT with multiple mechanisms[1].

EFEMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for EFEMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFEMP2 Human Pre-designed siRNA Set A contains three designed siRNAs for EFEMP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFHB Human Pre-designed siRNA Set A contains three designed siRNAs for EFHB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFHC1 Human Pre-designed siRNA Set A contains three designed siRNAs for EFHC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for EFHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFHD2 Human Pre-designed siRNA Set A contains three designed siRNAs for EFHD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFL1 Human Pre-designed siRNA Set A contains three designed siRNAs for EFL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNA1 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNA2 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNA3 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNA4 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNA5 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNA5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNB1 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNB2 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFNB3 Human Pre-designed siRNA Set A contains three designed siRNAs for EFNB3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFR3A Human Pre-designed siRNA Set A contains three designed siRNAs for EFR3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFR3B Human Pre-designed siRNA Set A contains three designed siRNAs for EFR3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFS Human Pre-designed siRNA Set A contains three designed siRNAs for EFS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EFTUD2 Human Pre-designed siRNA Set A contains three designed siRNAs for EFTUD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGF Human Pre-designed siRNA Set A contains three designed siRNAs for EGF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFL6 Human Pre-designed siRNA Set A contains three designed siRNAs for EGFL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFL7 Human Pre-designed siRNA Set A contains three designed siRNAs for EGFL7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFL8 Human Pre-designed siRNA Set A contains three designed siRNAs for EGFL8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFLAM Human Pre-designed siRNA Set A contains three designed siRNAs for EGFLAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFR Human Pre-designed siRNA Set A contains three designed siRNAs for EGFR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFR kinase inhibitor 3 (compound 2) is a bivalent ATP-allosteric EGFR kinase inhibitor with IC50s of

EGFR kinase inhibitor 4 (Compound 4) is a bivalent ATP-allosteric EGFR inhibitor (IC50: 1.8 nM for mutant EGFR (LRTMCS)). EGFR kinase inhibitor 4 can be used for research of NSCLC[1].

EGFR kinase inhibitor 5 (Compound 4c) is an orally active inhibitor for epidermal growth factor receptor (EGFR) kinase, with IC50 of 18.35 μM. EGFR kinase inhibitor 5 induces apoptosis. EGFR kinase inhibitor 5 exhibits anticancer and anti-inflammatory activity with low toxicity (LD50 range: 500-2000 mg/kg)[1].

EGFR kinase inhibitor 6 (Compound 4b) is an orally active inhibitor for epidermal growth factor receptor (EGFR) kinase, with IC50 of 24.34 μM. EGFR kinase inhibitor 6 induces apoptosis. EGFR kinase inhibitor 6 exhibits anticancer and anti-inflammatory activity with low toxicity (LD50 range: 500-2000 mg/kg)[1].

Egfr Mouse Pre-designed siRNA Set A contains three designed siRNAs for Egfr gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Egfr Rat Pre-designed siRNA Set A contains three designed siRNAs for Egfr gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

EGFR T790M/L858R-IN-4 is a potent EGFRT790M/L858R inhibitor with anticancer effects (WO2024064091A1; Example 14)[1].